Objective: The aim of this study was to investigate the expressions of CD147 and CK19 in hepatocellular carcinoma (HCC) and their clinical significance. Methods
Objective: We studied the inhibitory effect of human cholangiocarcinoma line (QBC939) treated by selective cyclooxygenase-2 (COX-2) inhibitor NS-398 and provide